Cautious Optimism Tempered by Sustainability Concerns: Analyst Upholds Hold Rating on Clover Health Investments

TipRanksMay 24 00:46

Bank of America raised Humana's target price to $376

Gelonghui FinanceMay 21 04:29

Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV), Agilon Health (AGL) and Boston Scientific (BSX)

TipRanksMay 20 09:01

Bank of America Securities Reaffirms Their Buy Rating on UnitedHealth (UNH)

TipRanksMay 20 08:55

Humana Analyst Ratings

BenzingaMay 20 05:34

Oscar Health Analyst Ratings

BenzingaMay 20 05:41

B of A Securities Maintains Neutral on Humana, Raises Price Target to $376

BenzingaMay 20 05:40

B of A Securities Maintains Buy on Oscar Health, Raises Price Target to $25

BenzingaMay 20 05:42

B of A Securities: Maintaining the Humana (HUM.US) rating, adjusted from neutral to neutral, and adjusted the target price from $342.00 to $376.00.

Zhitong FinanceMay 20 05:40

Analysts Offer Insights on Healthcare Companies: Oscar Health (OSCR), Puma Biotechnology (PBYI) and Patterson Companies (PDCO)

TipRanksMay 20 05:21

Analysts Offer Insights on Healthcare Companies: Herbalife (HLF), Alignment Healthcare (ALHC) and Vaxcyte (PCVX)

TipRanksMay 17 08:40

Stephens Adjusts Price Target on Molina Healthcare to $355 From $390, Maintains Equalweight Rating

MT NewswiresMay 16 04:36

Humana: Hold Rating Amid Short-Term Pressures and Long-Term Optimism

TipRanksMay 15 04:36

Buy Rating Affirmed: CVS Health's Proactive Strategies Counter Medicare Advantage Pressures and Unlock Growth Opportunities

TipRanksMay 15 04:38

Marpai's Strategic Turnaround and Growth Potential Justify Buy Rating

TipRanksMay 11 12:45

Stephens Adjusts Price Target on UnitedHealth to $565 From $545

MT NewswiresMay 10 08:18

Bernstein Adjusts Price Target on Cigna to $411 From $389

MT NewswiresMay 10 06:45

Wells Fargo: Maintaining the Oscar Health (OSCR.US) rating, adjusted from an increase in holdings to an increase rating, and the target price was adjusted from $20.00 to $24.00.

Zhitong FinanceMay 9 11:07

Oscar Health Analyst Ratings

BenzingaMay 9 07:52

Goldman Sachs Maintains Neutral on Oscar Health, Raises Price Target to $21

BenzingaMay 9 07:53